These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 26499308

  • 1. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M, Lee KH, Lee HS, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C.
    Prostate; 2016 Feb 15; 76(3):273-85. PubMed ID: 26499308
    [Abstract] [Full Text] [Related]

  • 2. S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells.
    Kang M, Lee HS, Lee YJ, Choi WS, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C.
    Urology; 2015 Jan 15; 85(1):273.e9-15. PubMed ID: 25440760
    [Abstract] [Full Text] [Related]

  • 3. Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.
    Dejima T, Imada K, Takeuchi A, Shiota M, Leong J, Tombe T, Tam K, Fazli L, Naito S, Gleave ME, Ong CJ.
    Prostate; 2017 Feb 15; 77(3):309-320. PubMed ID: 27775154
    [Abstract] [Full Text] [Related]

  • 4. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
    Chen Z, Jiang Q, Zhu P, Chen Y, Xie X, Du Z, Jiang L, Tang W.
    Prostate; 2019 Jan 15; 79(1):44-53. PubMed ID: 30178500
    [Abstract] [Full Text] [Related]

  • 5. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
    Shen P, Sun J, Xu G, Zhang L, Yang Z, Xia S, Wang Y, Liu Y, Shi G.
    Prostate; 2014 Jun 15; 74(9):946-58. PubMed ID: 24737412
    [Abstract] [Full Text] [Related]

  • 6. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, Wei M, Shen J, Hou J, Gao X, Xu C, Huang J, Zhao Y, Sun Y.
    J Urol; 2013 Dec 15; 190(6):2278-87. PubMed ID: 23845456
    [Abstract] [Full Text] [Related]

  • 7. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.
    Karacosta LG, Kuroski LA, Hofmann WA, Azabdaftari G, Mastri M, Gocher AM, Dai S, Hoste AJ, Edelman AM.
    Prostate; 2016 Feb 15; 76(3):294-306. PubMed ID: 26552607
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic effects of escin on human castration-resistant prostate cancer cells through the induction of apoptosis and G2/M cell cycle arrest.
    Piao S, Kang M, Lee YJ, Choi WS, Chun YS, Kwak C, Kim HH.
    Urology; 2014 Oct 15; 84(4):982.e1-7. PubMed ID: 25123426
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer.
    Choi SY, Xue H, Wu R, Fazli L, Lin D, Collins CC, Gleave ME, Gout PW, Wang Y.
    Clin Cancer Res; 2016 Jun 01; 22(11):2721-33. PubMed ID: 26755530
    [Abstract] [Full Text] [Related]

  • 11. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
    Ma B, Zhang H, Wang Y, Zhao A, Zhu Z, Bao X, Sun Y, Li L, Zhang Q.
    J Exp Clin Cancer Res; 2018 Sep 03; 37(1):210. PubMed ID: 30176898
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
    Dyshlovoy SA, Menchinskaya ES, Venz S, Rast S, Amann K, Hauschild J, Otte K, Kalinin VI, Silchenko AS, Avilov SA, Alsdorf W, Madanchi R, Bokemeyer C, Schumacher U, Walther R, Aminin DL, Fedorov SN, Shubina LK, Stonik VA, Balabanov S, Honecker F, von Amsberg G.
    Int J Cancer; 2016 May 15; 138(10):2450-65. PubMed ID: 26695519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.
    Nelius T, Martinez-Marin D, Hirsch J, Miller B, Rinard K, Lopez J, de Riese W, Filleur S.
    Cell Death Dis; 2014 May 08; 5(5):e1210. PubMed ID: 24810046
    [Abstract] [Full Text] [Related]

  • 16. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Mitani T, Harada N, Tanimori S, Nakano Y, Inui H, Yamaji R.
    J Nutr Sci Vitaminol (Tokyo); 2014 May 08; 60(4):276-82. PubMed ID: 25297617
    [Abstract] [Full Text] [Related]

  • 17. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
    Xiang S, Zou P, Tang Q, Zheng F, Wu J, Chen Z, Hann SS.
    Biochim Biophys Acta Gen Subj; 2018 Mar 08; 1862(3):589-599. PubMed ID: 29221985
    [Abstract] [Full Text] [Related]

  • 18. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G, Wang J, Feng C, Jiang H, Xu J, Ding Q.
    Oncotarget; 2016 Sep 27; 7(39):64309-64317. PubMed ID: 27602760
    [Abstract] [Full Text] [Related]

  • 19. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
    Wu X, Deng F, Li Y, Daniels G, Du X, Ren Q, Wang J, Wang LH, Yang Y, Zhang V, Zhang D, Ye F, Melamed J, Monaco ME, Lee P.
    Oncotarget; 2015 Dec 29; 6(42):44849-63. PubMed ID: 26636648
    [Abstract] [Full Text] [Related]

  • 20. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y, Sekine Y, Kato H, Furuya Y, Koike H, Suzuki K.
    Prostate; 2017 Mar 29; 77(4):337-349. PubMed ID: 27862098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.